Wednesday, April 19, 2017

Breaking Entertainment News: Verdi Productions "Man in Red Bandana" Documentary, narrated by Gwyneth Paltrow @GwynethPaltrow debuts at Tribeca on April 23rd

Breaking Entertainment News: Verdi Productions "Man in Red Bandana" Documentary, narrated by Gwyneth Paltrow @GwynethPaltrow debuts at Tribeca on April 23rd




EAST GREENWICH, Rhode Island, April 19th, 2017 - Investorideas.com reports that Verdi Productions announce the debut of their documentary film entitled "Man in Red Bandana" at Tribeca on Sunday, April 23rd. The film is part of a special screening and is an invitation-only event. The film will hit theaters and VOD platforms throughout the US in a limited day and date release in September 2017. This will be the third film released by Verdi Productions over the last two years, following Ten Thousand Saints, starring Ethan Hawke and Hailee Steinfeld, and Bad Hurt, starring Theo RossiKaren Allen, and Ashley Williams

The film was written and directed by Matthew J. Weiss with Chad A. Verdi and Joshua Sason producing.  Executive Producers are Michelle Verdi, Neil Cortel and Tom DeNucci.  The film editors are Doug Forbes and Sam Eilertsen.  The film is narrated by Gwyneth Paltrow with an original song performed by Lyle Lovett.

Man in Red Bandana tells the incredible story of Welles Crowther, a 24-year old civilian who gave his life saving others in the South Tower of the World Trade Center on 9/11. His heroics included carrying a woman on his shoulder down 17 flights of stairs. His bravery and courage only came to light eight months later due to an ordinary object - a red bandana. Through interviews, archive footage, re-creations and animation, the film depicts Welles' story in an engaging and educational manner. The ending depicts the diverse ways that Welles is honored throughout the United States leading to the revelation of a secret about Welles that can only be described as beautifully inspirational. 

Verdi stated, "Many of Welles' family and friends will be in attendance for this very special screening. It's truly an honor to be able to share Welles' incredible story with the world."

Verdi and Sason will donate all net profits to the Welles Remy Crowther Trust


Chad A. Verdi on IMDB

Man in Red Bandana Trailer  

Man in Red Bandana on IMDB 

Verdi Productions http://www.verdifilms.com

Verdi Productions is a fully-funded film production company located in East Greenwich, RI, with additional satellite offices in Edgartown, MANew York City and Los Angeles. The company pursues all aspects of filmmaking -- carrying projects from concept through post-production. 

Over the past 6 years, managing partner Chad A. Verdi, and his investment partners have invested over $100 million dollars into sixteen feature films. Verdi has produced four films in partnership with Emma Tillinger Koskoff and the legendary Martin Scorsese. Verdi produced Bleed For This (Miles TellerAaron Eckhart, Katey Sagal, Ciaran Hinds), and executive produced Silence (directed by Martin Scorsese and starring Liam NeesonAndrew GarfieldAdam Driver), Bad Hurt (starring Theo Rossi, Karen Allen, Ashley Williams) and the documentary The 50 Year Argument (directed by Martin Scorsese and David Tedeschi).

Stay updated by visiting our Facebook page at: https://www.facebook.com/verdiproductions

Chad A. Verdi - Producer of Bleed for This, Silence
President, Verdi Productions

Verdi Productions
214 Main Street
East Greenwich, Rhode Island 02818

For further information, please contact:


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Friday, April 07, 2017

New Entertainment Stock Added to Investorideas Directory


Entertainment, Biotech, Mining, Renewable Energy, Luxury Brands, Energy and Tech/Robotics (AI) Stocks Added to Investorideas.com



Point Roberts, WA, Delta BC – April 7, 2017 – Investorideas.com, a global news source and investor resource covering actively traded sectors announces this week’s additions to its investor membership, including global stock directories in biotech, mining, renewable energy, entertainment, luxury brands, and robotics- artificial intelligence.

The newest biotech companies include multiple companies involved in the treatment of cancers, with one, Midatech Pharma Plc (NasdaqCM:MTP) using gold nanoparticle technology.

Other new stocks within the sector this week are companies treating hypertension (PAH), muscular dystrophy and Alzheimer’s disease respectively.

Also included is a cross-over from the tech/robotics sector, Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS), a global technology leader in robotic-assisted vascular interventions, whose CorPath® System is the first FDA-cleared medical device to bring robotic precision to interventional procedures.

The latest mining stock additions are both Canadian Stock Exchange (CSE) listed companies, with one involved in gold mining operations and the other, EnviroLeach Technologies Inc. (CSE: ETI) offering a unique, cost-effective and environmentally friendly alternative for the extraction of precious metals.

EnviroLeach crosses into the greentech sector which is also adding ConEd (ED) due to its increasing commitment to energy efficiency and a bioenergy company that is developing a process to convert renewable resources into hydrocarbons through fermentation.

Canadian outerwear manufacturer Canada Goose Holdings Inc. (NYSE: GOOS; TSX: GOOS.TO) has been added to the luxury brands stock list and the CSE-Listed energy company Squatex Energy and Ressources Inc. (CSE:SQX) has been added to the Oil and Gas Stocks directory.

Rounding out this week’s additions is the entertainment stock Cinedigm (NasdaqGM: CIDM) which provides premium feature films and series to digital platforms including iTunes, Netflix, and Amazon; cable and satellite providers including Comcast, Dish Network and DirecTV; and major retailers including Walmart and Target.

Investorideas.com tracks companies in high profile trading sectors and makes ongoing additions to its stock directories for each sector.  Listing for the stock directories include companies on the TSX, OTC, NYSE, NASDAQ and global stock exchanges.
   
New Biotech Companies Added to Investorideas directory:
AbbVie Inc. (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries.

IsoRay, Inc. (NYSE MKT: ISR) designs and develops innovative and personalized brachytherapy products that effectively treat many forms of cancer. We believe in pioneering solutions for life beyond your cancer. Isoray Inc, through its subsidiary, IsoRay Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body.

Midatech Pharma Plc (NasdaqCM:MTP) is an international specialty pharmaceutical company focused on oncology and other therapeutic areas with a US commercial operation marketing four cancer care supportive products, and co-promoting two others. Midatech's strategy is to internally develop oncology products and collaborate with partners in other therapy areas, and to drive growth both organically and through strategic acquisitions. The Company's R&D activities are supported by two breakthrough drug delivery technologies: Q-Sphera for sustained release and our proprietary gold nanoparticles.

Moleculin Biotech, Inc. (NasdaqCM: MBRX) is a preclinical stage pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on discoveries made at M.D. Anderson Cancer Center. Our lead product candidate is Annamycin, an anthracycline for the treatment of relapsed or refractory acute myeloid leukemia, more commonly referred to as AML. We also have two preclinical small molecule portfolios, one of which is focused on the modulation of hard-to-target tumor cell signaling mechanisms and the recruitment of the patient's own immune system. The other portfolio targets the metabolism of tumors.

SteadyMed Ltd. (NasdaqGM: STDY) is a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value diseases with unmet parenteral delivery needs. The company's lead drug product candidate is Trevyent, a development stage drug product that combines SteadyMed's PatchPump technology with treprostinil, a vasodilatory prostacyclin analogue to treat pulmonary arterial hypertension (PAH). SteadyMed intends to commercialize Trevyent in the U.S. and has signed an exclusive license and supply agreement with Cardiome Pharma Corp. for the commercialization of Trevyent in Europe, Canada and the Middle East. SteadyMed has offices in San Ramon, California and Rehovot, Israel.

Summit Therapeutics plc (NasdaqGM:SMMT) is a biopharmaceutical company focused on the discovery, development and commercialisation of novel medicines for indications for which there are no existing or only inadequate therapies. Summit is conducting clinical programs focused on the genetic disease, Duchenne muscular dystrophy, and the infectious disease, Clostridium difficile infection.

vTv Therapeutics Inc. (NasdaqGM: VTVT) is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and Type 2 diabetes as well as treatment of inflammatory disorders and the prevention of muscle weakness.

New Mining Companies Added:
EnviroLeach Technologies Inc. (CSE: ETI) has developed a unique, cost-effective and environmentally friendly alternative to cyanide for the hydrometallurgical extraction of precious metals for the mining and E-waste sectors. The patent-pending EnviroLeach process is safe, eco-friendly, and provides comparable leach kinetics to high intensity cyanide on most ores, concentrates and tailings.

Miramont Resources Corp. (CSE:MONT) is engaged in the acquisition, exploration and development of mineral properties in Canada. Its current focus is to conduct the proposed exploration program on the Midas Gold Property, along with continuing to identify and potentially acquire additional property interests, assess their potential and engage in exploration activities.

New Renewable Energy Companies Added:
Consolidated Edison Inc. (NYSE: ED) subsidiary ConEdison Solutions is a leading energy services company that provides renewable energy, sustainability services, cost-effective energy efficiency solutions, demand response, and energy performance contracting. The company serves commercial, industrial, residential and government customers, as well as universities, public school districts, and hospitals nationwide. Offering innovative products, financial stability, and a commitment to customer service, the company has offices in Valhalla, New York; Burlington, Massachusetts; Cherry Hill, New Jersey; Falls Church, Virginia; Tampa, Florida; Overland Park, Kansas, Nashville, Tennessee; and Bloomington, Minnesota. The company's dedicated team of energy professionals delivers a broad range of energy solutions. Con Edison Solutions offers programs and services designed to help customers achieve their individual energy objectives and is accredited as an Energy Services Provider (ESP) by the National Association of Energy Service Companies (NAESCO).

Global Bioenergies (Paris: ALGBE) is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the performance of its process, operates an industrial pilot, has started operations at its demo plant in Germany, and is preparing its first full-scale plant through a joint venture with Cristal Union, named IBN-One. The company also replicated its achievement to propylene and butadiene, two members of the gaseous olefins family, key molecules at the heart of petrochemical industry.

New Entertainment Companies Added:
Cinedigm (NasdaqGM: CIDM) powers custom content solutions to the world's largest retail, media and technology companies. We provide premium feature films and series to digital platforms including iTunes, Netflix, and Amazon, cable and satellite providers including Comcast, Dish Network and DirecTV, and major retailers including Walmart and Target. Leveraging Cinedigm's unique capabilities, content and technology, the Company has emerged as a leader in the fast-growing over-the-top channel business, with four channels under management that reach hundreds of millions of devices while also providing premium content and service expertise to the entire OTT ecosystem.

New Luxury Brand Companies Added:
Canada Goose Holdings Inc. (NYSE: GOOS; TSX: GOOS.TO) Founded in a small warehouse in Toronto, Canada 60 years ago, Canada Goose has grown into a global outerwear brand. Canada Goose is a designer, manufacturer, distributor and retailer of premium outerwear for men, women and children. The Company’s jackets are sold in 36 countries around the world, including in two owned retail stores and four e-commerce stores.

New Energy Companies Added:
Squatex Energy and Ressources Inc. (CSE:SQX) is a junior oil and gas exploration company established in 2001 which main activity is to carry out works and studies aiming at the evaluation and the development of the oil and gas potential of a territory of 656,093 hectares under exploration license in the Province of Québec, in which it is holding a 70% interest.

New Tech/Robotics – AI Companies Added:
Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS) is a global technology leader in robotic-assisted vascular interventions. The company's CorPath® System is the first FDA-cleared medical device to bring robotic precision to interventional procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance guide catheters, stents, and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement during manual procedures. Corindus stands behind its product with its unique $1,000 hospital credit "One Stent Program."

Read this release in full at  

Investorideas.com global stock directories are part of the membership program on the site, accessed either by login and password or available in PDF format.  The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.

Sectors we cover include tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security (including biometrics), Latin America, sports, entertainment, luxury brands and gaming.

The Investorideas.com content portfolio goes beyond the www.investorideas.com site to include 12 blogs on Blogger.com, 7 Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com, all featuring Investorideas.com news and content.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Investor Ideas Directories for global investors:
From water stocks to gold and mining stocks, renewable energy, nanotech, defense, technology, biotech and more – use our stock directories and access them online 24/7 with login as a member to find your next big idea!

Services for Publicly traded companies: http://www.investorideas.com/Investors/Services.asp

Investorideas.com CSE service provider directory listing: http://thecse.com/en/services/services-for-listed-companies


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution,social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com
800-665-0411













Monday, April 03, 2017

Investorideas.com Newswire now on News360 app



Investorideas.com Newswire now on News360 app

Point Roberts, WA, Delta BC – April 3,  2017 – Investorideas.com, a global news source and investor resource covering actively traded sectors announces the Investorideas.com newswire is now live on the News360 app.
News360 app link for Investorideas.com newswire:  https://news360.com/p/investorideas
About News360 app https://news360.com/
•         Qualified Audience - 6M+ News360 users
•         Intelligent Engagement - Average CTR of 4%+ and 1+ minute time on page
•         Sticky Engagement - 30% of News360 sessions are longer than 10 minutes

Learn more about the Investorideas.com newswire and how to publish your news:

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.  

Sectors we cover include tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security (including biometrics), Latin America, sports, entertainment, luxury brands and gaming.

The Investorideas.com content portfolio goes beyond the www.investorideas.com site to include 12 blogs on Blogger.com, 7 Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com, all featuring Investorideas.com news and content.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas


Services for Publicly traded companies: http://www.investorideas.com/Investors/Services.asp



Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com

800-665-0411